- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05680285
Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment
December 25, 2022 updated by: Uşak University
Clinical and Radiographic Evaluation of Low Level Laser Therapy in Primary Tooth Pulpotomy Treatment
In our study, it was aimed to compare the long-term effectiveness of diode laser and low level laser therapy and primary tooth amputation treatments using calcium hydroxide (LLLT+CH) in primary second molars with deep dentinal caries.
Ninety patients ( 42 Gırl, 48 Boy) aged 6-9 years with deep dentin caries in the mandibular second molar were included in the study.
The patients were randomly selected according to the treatment to be applied and divided into two groups as the diode laser group (N=45) and the LLLT+CH group (N=45).
The patients were called for control appointments at the 1st, 3rd, 6th and 12th months after the treatment, and both clinical and radiographic follow-ups were performed.
Chi-square and Fisher's Exact tests were used to compare categorical variables according to groups in statistical analysis, and p<0.05 was considered significant.
When the study results at the end of 12 months were evaluated, the diode laser group had a clinical success rate of 95.6%, and a success rate of 93.3% radiologically; The LLLT+CH group had a success rate of 97.7% clinically and 90.9% radiologically.
There was no statistically significant difference between the success rates of the groups (p>0.05).
According to the clinical and radiographic results of our study, it was determined that diode laser and LLLT+CH amputations showed similar success rates in primary second molars with deep dentin caries.
It has been seen that both methods can be used safely in primary tooth amputations.
It is thought that clinical and histological studies and studies examining the effectiveness of dental laser applications in primary tooth amputation treatment are needed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Uşak, Turkey, 64200
- Uşak University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 9 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Clinical Criteria
- No systemic disease
- Not allergic to the materials used
- Children with scores of 1 and 2 according to the Frankel behavioral scale
- Those who have erupted permanent first molars
- The one in occlusion with the opposing tooth
- Not having bad oral habits
- No structural anomaly in the teeth
- No spontaneous or nocturnal pain
- No sensitivity to palpation or percussion
- Abscess and fistula formation free
- No pathological mobility
- During treatment, pulp bleeding is controlled within 5 minutes.
- With a crown that can be made of stainless steel crown (PÇK)
Radiographic Criteria
- Having a deep dentin caries lesion very close to the pulp
- No resorption in the bifurcation and periapical area
- Periodontal space is healthy and there is no periapical region pathology
- Absence of internal and external root resorption in roots
- No calcified masses in the pulp
- Teeth that did not exceed one-third of the physiological root resorption were included in the study.
Exclusion Criteria
-Children with a score of 1 and 4 on the Frankel Scale were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: diode laser pulpotomy
|
diode laser was applied during the pulpotomy procedure
|
|
Experimental: low level diode laser pulpotomy
|
Low-dose diode laser was applied during the pulpotomy procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
radiographic success of treatments at the end of 12 months
Time Frame: 12 months
|
teeth without any signs of pathological internal and external root resorption, enlargement of the periodontal space, and radiolucency in the periapical and furcation region
|
12 months
|
|
clinical success of treatments at the end of 12 months
Time Frame: 12 months
|
teeth without any of the signs of spontaneous pain, tenderness on palpation and percussion, pathological mobility, sinus tract or gingival abscess form, lymphodanepathy in the relevant region
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tugba YIGIT, Uşak University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
May 30, 2022
Study Completion (Actual)
May 30, 2022
Study Registration Dates
First Submitted
December 16, 2022
First Submitted That Met QC Criteria
December 25, 2022
First Posted (Estimate)
January 11, 2023
Study Record Updates
Last Update Posted (Estimate)
January 11, 2023
Last Update Submitted That Met QC Criteria
December 25, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- UsakU10
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulpotomy
-
University of Health Sciences LahoreNot yet recruitingIrreversible Pulpitis | Pulpotomy | MTA Vital Tooth PulpotomyPakistan
-
King Abdullah University HospitalJordan University of Science and TechnologyCompleted
-
Nourhan M.AlyAlexandria UniversityTerminated
-
Aydin Adnan Menderes UniversityCompleted
-
King Abdulaziz UniversityCompleted
-
Ain Shams UniversityCompletedPulpotomy | Tooth RestorationEgypt
-
Izmir Katip Celebi UniversityCompletedPrimary Teeth | Pulpotomy
-
Future University in EgyptRecruiting
-
Shaheed Zulfiqar Ali Bhutto Medical UniversityCompleted
Clinical Trials on diode lazer
-
Izmir Katip Celebi UniversityEnrolling by invitation
-
South Valley UniversityNot yet recruiting
-
South Valley UniversityRecruitingDiabetes ComplicationsEgypt
-
Cairo UniversityUnknown
-
Yuzuncu Yıl UniversityCompleted
-
Patricia LordeloUniversity of MessinaRecruiting
-
Universidade Federal de Sao CarlosFundação de Amparo à Pesquisa do Estado de São Paulo; Centro de Pequisas de...Completed
-
Hams Hamed AbdelrahmanCompletedDiabetes Mellitus | XerostomiaEgypt
-
Rinaldo Roberto de Jesus GuirroCompleted